QIU, YAO-LING,GAO, XURI,LI, WEI,CAO, HUI,JIN, MEIZHONG,KASS, JORDEN,PENG, XIAOWEN,OR, YAT SUN
申请号：
CA3017020
公开号：
CA3017020A1
申请日:
2017.03.06
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: X-A -Y -L-R (I) which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
